UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

Thrombosis and Coagulopathy in COVID-19

Current problems in cardiology, 2021-03, Vol.46 (3), p.100742-100742, Article 100742

2021

Link zum Volltext

Verfügbarkeit prüfen

Which events to consider in the study of venous thromboses in pancreatic cancer patients? Authors' reply

European journal of internal medicine, 2023-03, Vol.109, p.116-116

2023

Link zum Volltext

Verfügbarkeit prüfen

Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2

Oncology letters, 2016-07, Vol.12 (1), p.727-730

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

Clinical & translational oncology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

PloS one, 2023-05, Vol.18 (5), p.e0266305-e0266305

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives

TH open : companion journal to thrombosis and haemostasis, 2021-07, Vol.5 (3), p.e376-e386

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

Journal of clinical oncology, 2021-04, Vol.39 (10), p.1108-1118

2021

Link zum Volltext

Verfügbarkeit prüfen

Preface

Best practice & research. Clinical haematology, 2022-03, Vol.35 (1), p.101355, Article 101355

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-utility of apixaban and rivaroxaban in the thromboprophylaxis of cancer patients treated with chemotherapy in Spain

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24102-e24102

2022

Link zum Volltext

Verfügbarkeit prüfen

Preface

Best practice & research. Clinical haematology, 2022-03, Vol.35 (1), p.101355-101355

2022

Link zum Volltext

Verfügbarkeit prüfen

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

British journal of cancer, 2018-04, Vol.118 (8), p.1056-1061

2018

Link zum Volltext

Verfügbarkeit prüfen

Evolution of pancreatic ductal adenocarcinoma diagnosis during the last decade

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.670-670

2023

Link zum Volltext

Verfügbarkeit prüfen

Tratamiento con fulvestrant en mujeres posmenopáusicas con cáncer de mama avanzado tras tratamiento hormonal previo

Medicina clínica, 2009-09, Vol.133 (10), p.371-374

2009

Link zum Volltext

Verfügbarkeit prüfen

Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18744-e18744

2022

Link zum Volltext

Verfügbarkeit prüfen

Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18742-e18742

2022

Link zum Volltext

Verfügbarkeit prüfen

MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.602-602

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.586-586

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.188-188

2022

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological biliary tract cancer characterization: A patient cohort from the Spanish RETUD registry

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.480-480

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Thrombosis and Coagulopathy in COVID-19

Which events to consider in the study of venous thromboses in pancreatic cancer patients? Authors' reply

Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2

Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

Preface

Cost-utility of apixaban and rivaroxaban in the thromboprophylaxis of cancer patients treated with chemotherapy in Spain

Preface

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

Clinical characteristics and survival trends of patients with metastatic colorectal cancer (mCRC) and peritoneal carcinomatosis who receive metastases surgery in a Spanish cohort

Relationship between inflammatory indexes and Khorana score (KS) with prognosis and survival in pancreatic ductal adenocarcinoma (PDAC)

Clinical and survival characteristics of patients with BRAF-mutated metastatic colorectal cancer (mCRC) who receive metastases surgery in a Spanish cohort

Evolution of pancreatic ductal adenocarcinoma diagnosis during the last decade

Tratamiento con fulvestrant en mujeres posmenopáusicas con cáncer de mama avanzado tras tratamiento hormonal previo

Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning

Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning

MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry

Analysis of clinical characteristics and survival trends of BRAF mutated metastatic colorectal cancer (mCRC) patients receiving metastases surgery

Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer

Analysis of survival trends, clinical, and molecular characteristics of patients with early-onset colorectal cancer (EOCRC)

Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile

Epidemiological biliary tract cancer characterization: A patient cohort from the Spanish RETUD registry

Suchergebnisse filtern